Johnson & Johnson and Bank of America Merrill Lynch participated in the Q3 earnings season on October 7, 2026.
1 report, 1 independent
Updated Wed 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Johnson & Johnson and Bank of America Merrill Lynch participated in the Q3 earnings season on October 7, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Bank of America Merrill Lynch
investment bank
Related events
- Johnson & Johnson and Recordati Industria Chimica E Farmaceutica are noted as large-cap healthcare companies.
- Johnson & Johnson and Realty Income are noted for competing dividend investment vehicles.
- A fund trimmed its position in Johnson & Johnson (JNJ) stock and disclosed the transaction via financial filings with the SEC.
- Johnson & Johnson is scheduled to present at a major industry summit, likely related to the Deutsche Bank Healthcare Summit.
- Eli Lilly outperformed Johnson & Johnson stock over the past year.